The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Krukov A.I.

Sverzhevsky Moscow Scientific and Practical Othorhinolaryngology Center, Moscow

Nosulia E.V.

Kunel’skaya N.L.

N.I. Pirogov Russian National Research Medical University, Moscow, Russia, 117997;
L.I. Sverzhevsky Moscow Research and Practical Centre of Otorhinolaryngology, Moscow Health Department, Moscow, Russia, 117152

Kim I.A.

Kafedra otorinolaringologii RMAPO, Moskva

Nenasheva N.M.

Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, Moscow, Russia

Thao N.T-F.

N.I. Pirogov National Research Medical University, Moscow, Russia

Prospective areas of pharmacotherapy for allergic rhinitis

Authors:

Krukov A.I., Nosulia E.V., Kunel’skaya N.L., Kim I.A., Nenasheva N.M., Thao N.T-F.

More about the authors

Journal: Russian Rhinology. 2020;28(2): 101‑106

Read: 7164 times


To cite this article:

Krukov AI, Nosulia EV, Kunel’skaya NL, Kim IA, Nenasheva NM, Thao NT-F. Prospective areas of pharmacotherapy for allergic rhinitis. Russian Rhinology. 2020;28(2):101‑106. (In Russ.)
https://doi.org/10.17116/rosrino202028021101

Recommended articles:
Effi­cacy of combined therapy of prurigo adultorum with application of temgicoluril anxiolytic. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):210-216
Oxidative stress and depression in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):131-138

References:

  1. Min Y.G. The pathophysiology, diagnosis and treatment of allergic rhinitis. Allergy, Asthma & Immunology Research. 2010;2(2):65-76.
  2. Nguyen P.T., Vickery J., Blaiss M.S. Management of rhinitis: allergic and non-allergic. Allergy, Asthma & Immunology Research. 2011;3(3):148-156.
  3. Meltzer EO, Bukstein DA. The economic impact of allergic rhinitis and current guidelines for treatment. Annals of Allergy, Asthma & Immunology. 2011;106(suppl 2):12-16.
  4. Blaiss M.S. Allergic rhinitis: direct and indirect costs. Allergy and Asthma Proceedings. 2010;31:375-380.
  5. Nosulya E.V. Komorbidnost’ allergicheskogo rinita: osobennosti i znachenie v praktike otorinolaringologa. Spravochnik poliklinicheskogo vracha. 2010;5:51-54. (In Russ.).
  6. Leynaert B., Neukirch C., Kony S., Guenegou A., Bousquet J., Aubier M., Neukirch F. Association between asthma and rhinitis according toatopic sensitization in a population-based study. Journal of Allergy and Clinical Immunology. 2004;113:86-93.
  7. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998;351:1225-1232.
  8. Casale T.B., Dykewicz M.S. Clinical implications of the allergic rhinitis-asthma link. American Journal of the Medical Sciences. 2004;327:127-138.
  9. Kim C.W., Lee C.W., Hur G.Y., Ye Y.M., Park H.S. Evaluation and Control of Allergic Rhinitis in Adult Patients with Asthma (CARINA) in Korea. Korean Journal Asthma of Allergy and Clinical Immunology. 2007;27(4):248-256.
  10. Lin S.W., Wang S.K., Lu M.C., Wang C.L., Koo M. Acute rhinosinusitis among pediatric patients with allergic rhinitis: A nationwide, population-based cohort study. PLoS One. 2019;14(2):e0211547. https://doi.org/10.1371/journal.pone.0211547
  11. Byeon H. The association between allergic rhinitis and otitis media: A national representative sample of in South Korean children. Scientific Reports. 2019;9(1):1610. https://doi.org/10.1038/s41598-018-38369-7
  12. Bousquet J., Khaltaev N., Cruz A.A., Denburg J., Fokkens W.J., Togias A., Zuberbier T., Baena-Cagnani C.E., Canonica G.W., van Weel C., Agache I., Aït-Khaled N., Bachert C., Blaiss M.S., Bonini S., Boulet L-P, Bousquet P-J, Camargos P., Carlsen K-H, Chen Y., Custovic A., Dahl R., Demoly P., Douagui H., Durham S.R., van Wijk G.R., Kalayci O., Kaliner M.A., Kim Y-Y, Kowalski M.L., Kuna P., Le LT.T., Lemiere C., Li J., Lockey R.F., Mavale-Manuel S., Meltzer E.O., Mohammad Y., Mullol J., Naclerio R., O’Hehir R.E., Ohta K., Ouedraogo S., Palkonen S., Papadopoulos N., Passalacqua G., Pawankar R., Popov T.A., Rabe K.F., Rosado-Pinto J., Scadding G.K., Simons F. E.R., Toskala E., Valovirta E., van Cauwenberge P., Wang D-Y, Wickman M., Yawn B.P., Yorgancioglu A., Yusuf O.M., Zar H., Annesi-Maesano I., Bateman E.D., Ben Kheder A., Boakye D.A., Bouchard J., Burney W.W.P., Busse M., Chan-Yeung N.H., Chavannes A., Chuchalin W.K., Dolen Emuzyte R., Grouse L., Humbert M., Jackson C., Johnston S.L., Keith P.K., Kemp J.P., Klossek J-M, Larenas-Linnemann D., Lipworth B., Malo J-L, Marshall G.D., Naspitz C., Nekam K., Niggemann B., Nizankowska-Mogilnicka E., Okamoto Y., Orru M.P., Potter P., Price D., Stoloff S.W., Vandenplas O., Viegi G., Williams D. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update. Allergy. 2008;63(suppl 86):1-160.
  13. Leurs R., Church M.K., Taglialatela M. H1-antihistamines: Inverse agonism, anti-inflammatory actions and cardiac effects. Clinical & Experimental Allergy. 2002;32:489-498.
  14. Olusesi A.D., Undie N.B., Amodu J.E. Allergy history as a predictor of early onset adenoids/adenotonsillar hypertrophy among Nigerian children. International Journal of Pediatric Otorhinolaryngology. 2013;77(6):1032-1035. https://doi.org/10.1016/j.ijporl.2013.04.004
  15. Cho K.S., Kim S.H., Hong S.L., Lee J, Mun SJ, Roh YE, Kim YM, Kim HY. Local Atopy in Childhood Adenotonsillar Hypertrophy. American Journal of Rhinology. 2018;32(3):160-166. https://doi.org/10.1177/1945892418765003
  16. Sadeghi-Shabestari M., Jabbari Moghaddam Y, Ghaharri H. Is there any correlation between allergy and adenotonsillar tissue hypertrophy? International Journal of Pediatric Otorhinolaryngology. 2011;75(4):589-591. https://doi.org/10.1016/j.ijporl.2011.01.026
  17. Lee D.J., Chung Y.J., Yang Y.J., Mo J.H. The Impact of Allergic Rhinitis on Symptom Improvement in Pediatric Patients After Adenotonsillectomy. Clinical and Experimental Otorhinolaryngology. 2018;11(1):52-57. https://doi.org/10.21053/ceo.2017.00500
  18. Karatzanis A.D., Fragiadakis G., Moshandrea J., Zenk J., Iro H., Velegrakis G.A. Septoplasty outcome in patients with and without allergic rhinitis. Rhinology. 2009;47(4):444-449. https://doi.org/10.4193/Rhin08.126
  19. Kryukov A.I., Turovskij A.B., Bondareva G.P., Syomkina O.V. Principy lecheniya allergicheskogo rinita. Medicinskij Sovet. 2013;7:42-47. (In Russ.).
  20. Gushchin I.S. Patogenez allergicheskogo vospaleniya. Rossijskaya rinologiya. 1999;1:12-13. (In Russ.).
  21. Il’ina NI. Allergicheskij rinit. Consilium-medicum. 2000;2(8):338-343. (In Russ.).
  22. Nenasheva NM. Terapiya allergicheskogo rinita: kakoj antigistaminnyj preparat vybrat’? Russkij medicinskij zhurnal. 2015;9:514-552. (In Russ.).
  23. Nosulya E.V., Kim I.A., Luchsheva Yu.V., Izotova G.N. Komorbidnost’ allergicheskogo rinita — aktual’nost’ antigistaminnoj terapii v povsednevnoj praktike. Profilakticheskaya medicina. 2019;22(4):124-128. (In Russ.). https://doi.org/10.17116/profmed201922041124
  24. Bachert C. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis. Clinical Therapeutics. 2009;31(5):921-944. https://doi.org/10.1016/j.clinthera.2009.05.017
  25. Ciprandi G., Cirillo I., Vizzaccaro A., Tosca M.A. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study. Clinical & Experimental Allergy. 2004;34(6): 958-964.
  26. Walsh GM. Levocetirizine: an update. Current Medicinal Chemistry. 2006;13(22):2711-2715.
  27. Bachert C. Clinical and Experimental Allergy Review. 2005;5:40-43.
  28. Holgate S, Powell R, Jenkins M, Ali O. A treatment for allergic rhinitis: a view on the role of levocetirizine. Current Medical Research & Opinion. 2005;21(7):1099-1106.
  29. Nenasheva N.M. Rol’ antilejkotrienovyh preparatov v dostizhenii kontrolya bronhial’noj astmy. Medicinskij Sovet. 2017;18:44-55. (In Russ.). https://doi.org/10.21518/2079-701X-2017-18-44-55
  30. Razi C., Bakirtas A., Harmanci K., Turktas I., Erbas D. Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology. 2006;97:767-774
  31. Nayak A., Langdon R.B. Montelukast in the treatment of allergic rhinitis: an evidence-based review. Drugs. 2007;67:887-901. https://doi.org/10.2165/00003495-200767060-00005
  32. Virchow J.C., Mehta A., Ljungblad L., Mitfessel H. A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients. Journal of Asthma. 2010;47:986-993. https://doi.org/10.1080/02770903.2010.494753
  33. Tintinger G.R., Feldman C., Theron A.J., Anderson R. Montelukast: more than a cysteinyl leukotriene receptor antagonist? Scientific World Journal. 2010;10:2403-2413. https://doi.org/10.1100/tsw.2010.229
  34. Meltzer E.O., Malmstrom K., Lu S., Prenner B., Wei L.X., Weinstein S.F., Wolfe JD, Reiss TF. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebocontrolled clinical trial. Journal of Allergy and Clinical Immunology. 2000;105:917-922.
  35. Ciebiada M., Gorska-Ciebiada M, DuBuske LM, Górski P. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis. Annals of Allergy, Asthma & Immunology. 2006;97:664-671.
  36. Kurowski M., Kuna P., Gorski P. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal alelrgy inflammation. Allergy. 2004;58:280-288.
  37. Kim Mk., Lee Sy., Park Hs., Yoon Hj., Kim Sh., Cho Yj., Yoo Kh., Lee Sk., Kim Hk., Park Jw., Park Hw., Chung Jh., Choi Bw., Lee Bj., Chang Ys., Jo Ej., Lee Sy., Cho Ys., Jee Yk., Lee Jm., Jung J., Park Cs. A Randomized, Multicenter, Double-Blind, Phase Iii Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients with Asthma and Allergic Rhinitis. Clinical Therapeutics. 2018;40:7.
  38. Bylappa K., Wilma DSCR. Evaluation of efficacy of fixed dose combination of montelukast and levocetirizine compared to monotherapy of montelukast and levocetirizine in patients with seasonal allergic rhinitis. International Journal of Otorhinolaryngology and Head and Neck Surgery. 2018;4:467-472.
  39. Seresirikachorn K., Chitsuthipakorn W., Kanjanawasee D., Khattiyawittayakun L., Snidvongs K. Leukotriene Receptor Antagonist Addition to H1-Antihistamine Is Effective for Treating Allergic Rhinitis: A Systematic Review and Meta-analysis. American Journal of Rhinology. 2019;33(5):591-600.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.